Section 5: Airway clearance

Canadian Journal of Respiratory, Critical Care, and Sleep Medicine Revue canadienne des soins respiratoires et critiques et de la médecine du sommeil ISSN: 2474-5332 (Print) 2474-5340 (Online) Journal homepage: https://www.tandfonline.com/loi/ucts20 Section 5: Airway clearance Sherri Lynne Katz & on behalf of the CTS Pediatric Home Ventilation Guidelines Panel To cite this article: Sherri Lynne Katz & on behalf of the CTS Pediatric Home Ventilation Guidelines Panel (2018) Section 5: Airway clearance, Canadian Journal of Respiratory, Critical Care, and Sleep Medicine, 2:sup1, 32-40, DOI: 10.1080/24745332.2018.1494979 To link to this article: https://doi.org/10.1080/24745332.2018.1494979 Published online: 23 Oct 2018. Submit your article to this journal Article views: 166 View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalinformation?journalcode=ucts20

CANADIAN JOURNAL OF RESPIRATORY, CRITICAL CARE, AND SLEEP MEDICINE 2018, VOL. 2, NO. S1, 32 40 https://doi.org/10.1080/24745332.2018.1494979 PEDIATRIC HOME MECHANICAL VENTILATION: A CANADIAN THORACIC SOCIETY CLINICAL PRACTICE GUIDELINE Section 5: Airway clearance Sherri Lynne Katz on behalf of the CTS Pediatric Home Ventilation Guidelines Panel Division of Respiratory Medicine, Children s Hospital of Eastern Ontario and University of Ottawa, Ottawa, Ontario, Canada Introduction Airway patency is required in order to maintain adequate ventilation. Inhaled material impacted in the peripheral airways is moved out to the larger airways and hence to the oropharynx by mucociliary clearance. If this mechanism is inadequate to clear entrapped material from the larger airways, then coughing is utilized to achieve adequate airway clearance. An adequate cough requires (1) a deep inspiration; (2) forceful expiration against a closed glottis; and (3) subsequent opening of the glottis, producing sufficient velocity of expiratory flow to shear mucoid material attached to the airway walls into the air stream. 1,2 Coughing therefore requires the ability to achieve adequate inspiration (needing sufficient inspiratory muscle strength), the ability to close the glottis and reasonable expiratory muscle strength for forced expiration. Patients with respiratory muscle weakness that is severe enough to require ventilatory support are unlikely to have adequate cough clearance. This is further compromised in patients receiving invasive ventilation by the presence of the tracheostomy interfering with glottic closure. Recurrent atelectasis and pneumonia are therefore frequent complications in these patients. 3 6 Additionally, decreased range of motion of the chest wall due to weakened inspiratory muscles may result in reduced chest wall compliance, with decreased lung volumes also leading to micro-atelectasis and reduction in elastic properties of lung tissues, further compromising the ability to cough. 7 Supportive airway clearance techniques 8 have been developed to assist with removal of secretions from the lungs and airways 5,8 11 and should therefore be considered in these patients. Noninvasive airway clearance strategies aim to (1) increase inspired lung volume to reach maximum insufflation capacity (MIC), through Lung Volume Recruitment (LVR) or breath-stacking ; (2) increase expiratory force in the expulsive phase of cough with manually assisted coughing by applying abdominal pressure; and/or (3) acceleration of expiratory airflow through application of positive and negative airway pressures with mechanical in-exsufflation (MI-E). Physiotherapy techniques assist with mobilization of secretions from the distal airways and agents that alter viscosity of secretions may aid with airway clearance. Finally, in individuals with tracheostomies, suctioning is often also applied to clear secretions from the large airways. These approaches have been applied in individuals with neuromuscular disease and spinal cord injury who have impaired cough. They have not been studied in individuals without evidence of impaired cough efficacy. Recommendations are, therefore, based upon observational studies and professional consensus in these patient populations. Literature review: Methodology Searches were conducted looking for publications on (1) glossopharyngeal breathing, lung volume recruitment and airway clearance in respiratory muscle weakness and/or neuromuscular disease; (2) physiotherapy techniques (including positive end expiratory pressure, percussion, active cycle of breathing, high frequency chest wall oscillation and intra-pulmonary percussive ventilation in individuals with respiratory muscle weakness and/or neuromuscular disease; and (3) airway clearance in tracheostmomized individuals. We aimed at identifying all studies published in English and French. We searched Cochrane and MEDLINE databases (1966 August 24, 2015). As well, we handsearched reference lists from identified publications in order to add any missed studies. We also searched the web sites of large associations of physicians and health professionals in the field of respiratory medicine, intensive care, nursing and respiratory therapy for reviews, consensus statements and clinical practice guidelines. We obtained the full publication of all relevant studies identified Results We retrieved 218 English-language publications that were relevant to our inclusion criteria and dealt with home mechanical ventilation in children. Editorials and opinions, general reviews, publications with clinical practice guidelines and publications on the type of equipment used for airway clearance were eliminated. Publications dealing solely with adult populations were eliminated as well. We were then left with 15 publications dealing specifically with cohorts including children with respiratory muscle weakness and/or neuromuscular disease, and/or on home mechanical ventilation (HMV) (including the search terms home care services, hospitalbased, long-term care, outpatients, palliative care, chronic) CONTACT Sherri Lynne Katz skatz@cheo.on.ca Children s Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, ON K1H 8L1 ß 2018 Canadian Thoracic Society

CANADIAN JOURNAL OF RESPIRATORY, CRITICAL CARE, AND SLEEP MEDICINE 33 which dealt with airway clearance (insufflation, inspiratory positive pressure ventilation (IPPV), manual or mechanical insufflation, in-exsufflation, lung volume recruitment) (Table 1). These studies largely describe experiences at single institutions, in case series, where airway clearance was part of a treatment plan which also included ventilatory support. An additional three studies were found which examined physiotherapy techniques in this population, including positive expiratory pressure, active cycle of breathing, high-frequency chest wall oscillation (HFCWO), percussion, intrapulmonary percussive ventilation (IPPV). These consisted of 2 case reports and 1 randomized controlled trial. There were no systematic reviews of either airway clearance or physiotherapy in children. There is only one pediatric study reporting on LVR. 12 Airway clearance in individuals at risk of or requiring noninvasive ventilation Lung volume recruitment Lung volume recruitment (LVR) is the most commonly employed technique to assist with cough and airway clearance in individuals with respiratory muscle weakness. It is a means of stacking breaths to achieve maximal lung insufflation capacity, expand the chest wall and fill the lungs. Insufflation may also help to maintain chest wall range of motion and lung compliance. 9 By increasing lung volume, LVR has also been shown to improve cough efficacy. LVR was shown to increase peak cough flows ((PCF), a measure of cough capacity achieved by having an individual cough as forcefully as possible into a peak flow meter) above those achieved by maximal unassisted coughs or coughs assisted by conventional physiotherapy or noninvasive ventilation. 5 Intermittent positive pressure-assisted hyperinsufflation, a manual insufflation technique that assists patients with inflating the lungs above what they would be able to do without assistance, has specifically been shown to improve PCF in pediatric neuromuscular disorders in children as young as 6 years. 12 Most studies performed to date have incorporated LVR as an integral part of an overall approach to care, making it difficult to assess its impact alone on clinical course. 13 LVR may be applied in individuals at risk of requiring or already receiving noninvasive ventilation to increase lung volumes above spontaneous vital capacity and may manually or mechanically assist cough, using techniques of: 1. Glossopharyngeal breathing (air stacking or frog breathing, 14 which requires no equipment but is a difficult technique to master. It involves taking a breath and holding it, followed by 15 20 gulps of air while the soft palate seals off the naspharynx. 15 2. Manual Insufflation with a self-inflating resuscitation bag and patient interface with a one-way valve. This technique has been used in adults with neuromuscular disease and is described in detail at http://www.irrd.ca/ education. The equipment is readily available and inexpensive, lightweight, relatively small, requires no external power and is easily portable. Users can also provide direct feedback to caregivers so inflation occurs to an adequate, but comfortable volume, 8 to assist a subsequent cough maneuver. 9,16 18 It may be accompanied by manually assisted cough, during which an abdominal thrust is applied during expiration. 3. Mechanical In-exsufflation using the Respironics Inexsufflator provides mechanically assisted cough (http:// www.coughassist.com), by delivering positive pressure breaths, usually followed by a rapid negative pressure to mimic a cough. 3,5,19 It is, however, relatively expensive, cumbersome, requires external power and is less easily portable. Literature review Manual insufflation Manual insufflation with a bag and mask containing a oneway valve or glossopharyngeal breathing technique has also been shown to significantly increase PCF as compared to unassisted cough, to a level comparable to that obtainable with an MI-E. 14,16,20 22 The PCF achievable in adults with manual LVR technique is 1.8 times greater than with an unassisted cough. 16,23 Mechanical in-exsufflation (MI-E) One case series, which studied mainly adults, demonstrated an improvement in MIC (the maximum volume of air that can be held in the lungs with a closed glottis after breathstacking), despite a decrease in vital capacity, over 0.5 24 years of follow up in 282 patients with neuromuscular disease. 24 Integrating the MI-E into an overall plan of care has also been successful in some case series in avoiding hospitalization, pneumonias, episodes of respiratory failure and tracheostomy. 3,25 28 A similar protocol using noninvasive positive pressure ventilation (NIV) and LVR has been used in a prospective cohort study to avoid intubation and death in episodes of acute respiratory failure in 79.2% of adults with neuromuscular disease, and in a series of children under 3 years of age with Spinal Muscular Atrophy type 1. 29,30 It is difficult to determine, however, whether the improved outcomes in these studies were due to NIV or the MI-E. A single cohort study of adults and children using manual insufflation twice daily (as per self-report) demonstrated improvement in MIC and PCF over time. 7 In a largely pediatric population, there has only been 1 retrospective review of long-term regular (once a day to every 4 hours) use of MI-E in 62 individuals with neuromuscular disease and impaired cough (age range 3 months to 28.6 years). The treatment modality was used for a median duration of 13.4 months. 31 Six percent of participants experienced an improvement in chronic atelectasis and 8% noted a reduction in frequency of pneumonias, although the number of acute lower respiratory tract infections was too small to permit meaningful comparison with a pretreatment period. In an analysis of a patient registry for Spinal Muscular Atrophy Type I, the use of an

34 S. KATZ MI-E device had a significant independent impact in reducing death. 32 LVR maneuvers (manual and mechanical) have been performed for more than 650 patient-years and hundreds of applications without dangerous side effects. 23,33 Excellent tolerance ( 90%) of LVR has been reported in children. 9,31,34 LVR may cause chest discomfort due to stretching of muscles of the chest wall. There are case reports of nausea and abdominal distension, pneumothorax or pneumomediastinum 35 in adults and premature ventricular contractions (in an adolescent with DMD and cardiomyopathy). 9 Optimal pressure settings for manual and mechanical inexsufflation are not known and range in the literature from 15 to 45 cm H 2 O.36 Higher pressures (40 cm H 2 O) can increase vital capacity greatly in children. 34 Pressures need to be individually determined and titrated. Furthermore, pressures may require readjustment during periods of infection, when respiratory compliance may be diminished. Also there may be physiologic limits, outside of which MI-E has been recommended. 37 Additional therapies The use of chest physiotherapy techniques, including HFCWO and IPPV, are controversial and not fully established in individuals with respiratory muscle weakness. 8,11,38 43 IPPV can improve clinical and radiographic evidence of atelectasis/ consolidation in some children (case series). 43 Asingle,short, randomized cross-over study showed preliminary benefit (i.e., increased weight of mucous collected) from IPPV, when added to manually assisted cough with forced expiratory technique, in tracheostomized, hospitalized DMD patients with mucus hypersecretion. 42 Two case reports exist of use of HFCWO in children with neuromuscular disease, indicating some clinical benefit in ventilation and atelectasis. 44,45 Asingle pediatric randomized controlled trial in 23 children with neuromuscular disease or cerebral palsy compared HFCWO to standard physiotherapy techniques used three times day over a mean follow up of five months. Safety, tolerability and increased compliance were seen in those using HFCWO, although no differences between groups was seen in hospitalizations, antibiotic use or nocturnal oxygenation. 46 The only other study of HFCWO (uncontrolled) was conducted in adults with impaired cough, in which oxygen saturation improved and patients reported satisfaction with the therapy. 47,48 Similarly, agents that alter viscosity of secretions have not been well-studied in children with impaired cough. These therapies have been used for airway clearance in children with cystic fibrosis, who have normal cough capacity but copious, thick airway secretions. 8 On a case-by-case basis, in those with atelectasis, this treatment may be considered. 8 A discussion of the management of sialorrhea is beyond the scope of these guidelines but it is important to attempt to minimize sialorrhea in conjunction with using airway clearance techniques. Finally, management of associated comorbidities of the underlying condition that contribute to impaired airway clearance needs to be addressed. Obesity can reduce chest wall compliance and malnutrition decreases muscle mass, both of which further compromise cough effectiveness. 8 Aspiration of oral secretions and/or food, as well as gastroesophageal reflux, can also contribute to an increased volume of secretions for the individual to handle. 8 Clinical approach to airway clearance Optimal frequency of usage of LVR and MI-E is not known, although it has been shown that during the first 24 36 hours of illness, individuals with weak respiratory muscles experience a decline in forced vital capacity of 13 29%, as well as maximal inspiratory and expiratory pressures. 49 Airway clearance techniques are therefore critical at these times to prevent morbidity and mortality. Furthermore, the patient populations that will benefit most from these interventions have not been clearly determined. Lung and chest wall compliance, as well as bulbar function, determine the degree to which LVR can be performed. 13,50 It is, therefore, more likely that LVR will be most beneficial in those with a compliant chest wall and lungs, with preserved bulbar function. In addition, cooperation of the patient is required for successful application of these techniques, especially MI-E, in order that airway patency is maintained during the expiratory phase. 51 Appropriate patient selection is therefore critical. These techniques may be most applicable to patients with neuromuscular or chest wall disease and are less likely to be beneficial in those with obstructive airway diseases. 33 LVR has been recommended by Bach and Finder as the standard of care for neuromuscular patients. 3,11,13,25,26,52 54 American Thoracic Society guidelines from 2004 have suggested its implementation when baseline cough peak flow is <270 L/minute,11 maximum expiratory pressure <60 cm H 2 O, 11 or baseline forced vital capacity <40% predicted, in children and teens with neuromuscular disease. 54 Other guidelines for the management of Duchenne muscular dystrophy advocate for use of manual and mechanically assisted cough techniques during times of established infections. 55 Volume recruitment/deep lung inflation devices are listed as necessary equipment and critical therapy. 54 Manual or mechanically assisted coughing is recommended when patients experience hypoxemia and hypoventilation in the context of a respiratory infection, retained respiratory secretions, infections and/or atelectasis, as well as postoperatively if PCF is <270 L/minute or baseline MEP is <60 cm H 2 O. 56 They further suggest the use of insufflation (manual or mechanical) when FVC <40% predicted and the use of MI-E when: 1. respiratory infection is present and baseline PCF <270 L/minute (in older teen and adult patients); 2. baseline PCF <160 L/minute or MEP <40 cmh2o; or 3. baseline FVC <40% predicted (or <1.25 L) in older teen and adult patients. 54 It should be noted, however, that PCF in younger children varies and that values below 270 L/minute can be normal in boys younger than 11 years and girls younger than

CANADIAN JOURNAL OF RESPIRATORY, CRITICAL CARE, AND SLEEP MEDICINE 35 Table 1. Summary of the literature. Author (Year) Study type Ottonello (2011) 30 Retrospective chart review Patient number and condition Lung volume/flow Ventilator support Survival 16 with Spinal Muscular atrophy Type 1 under 3 years of age Gomez- Retrospective Merino (2002) 3 review 125 with Duchenne muscular dystrophy (included some children 14.9 years and older [< 34 years]) Bach (2008) 24 Case series 282 neuromuscular patients with VC <70% predicted (included some children) Tzeng (2000) 13 Observational study 94 individuals with neuromuscular disease, comparing 45 patients pre-protocol (of whom 45 had previous episodes of respiratory failure) vs. post-protocol In 46/78 patients with multiple measurements, MIC and passive lung insufflation capacity increased (462 260 and 365 289 ml) despite a decrease of VC of 209 97 ml 5 patients decannulated and weaned to noninvasive ventilation for 1.6 1.6 years 51 full-time NIV users had prolonged survival for 6.3 4.6 years Miske (2004) 31 Retrospective review Vianello (2005) 28 Observational study with historical controls 62 pediatric neuromuscular patients with impaired cough (MEP <60 cm H 2 O). 11 neuromuscular patients with respiratory tract infections in ICU (included 2 children) vs. 16 historical controls (included 2 children) Need for mini-tracheostomy or endotracheal intubation was lower in MI-E group than in the controls (2/11 vs. 10/16 cases, p ¼ 0.047). No differences in the number needing noninvasive ventilation or time on mechanical ventilation Respiratory findings Hospitalization/ Respiratory exacerbations Protocol of high span bi-level positive airway pressure and mechanical airway clearance reduced episodes of respiratory failure and hospitalization for children under 3 years of age, compared to historical controls (0.15 hospitalizations/year vs. 0.88 7.6 episodes/year) For the 10 patients who never used any ventilation, hospitalizations/year decreased from 1.4 0.84 to 0.03 0.11 (p ¼ 0.003). Significant differences also seen in noninvasive ventilator users in hospitalizations and days in hospital. Quality of life Patient satisfaction (continued)

36 S. KATZ Table 1. Continued. Patient number Author (Year) Study type and condition Lung volume/flow Ventilator support Survival Chatwin (2003) 5 Cross-sectional 22 patients with neuromuscular disease (including 8childrenage10 16 years) and 19 agematched controls Chatwin (2009) 73 Randomized crossover study 8 patients (age range 4 44 years) with sputum retention Kang (2000) 7 Observational cohort Oskoui (2007) 32 Retrospective analysis of patient registry McKim (2012) 74 Retrospective cohort study Bach (1995) 75 Cohort study with historical comparison 43 patients with neuromuscular conditions (including 3 patients with SMA) (age 11.2 4.0 years) Spinal Muscular Atrophy Type I (N ¼ 143) Duchenne muscular @ystrophy (N ¼ 22) Spinal Muscular Atrophy, receiving ventilation (N ¼ 10) MIC increased from 1402 þ/ 530 ml to 1711 599 ml (p< 0.001) in 30/43 patients. Those with increased MIC also increased assisted PCF from 3.7 1.4 to 4.3 1.6 L/s (p< 0.05) despite decreasing VC and unassisted PCF Annual decline of FVC was 4.7 percent-predicted a year before LVR and 0.5 percent-predicted a year after LVR initiation. (Difference ¼ 4.2 percent-predicted a year (95% confidence interval, 3.5 4.9; P<.000 Controlling for demographic and clinical care variables, MI-E showed a significant effect in reducing risk of death De Troyer (1981) 76 Cross-sectional study Dohna- Schwake, (2006) 12 Adolescents and adults with generalized neuromuscular disorders (N ¼ 10) Cross-sectional Various neuromuscular disorders (age 12.6 3.6 years, range 6 20 years) with PCF <160 L/min and/or history of chest infections (N ¼ 29) No difference in functional residual capacity, and static pulmonary compliance Augmentation of lung volumes: 69% increase in FIVC, 75% increase in PCF Respiratory findings Greatest increase in PCF seen with MI-E (235 111 vs. 169 90 (unassisted)) p< 0.01 Treatment time shorter with inexsufflation (30 min vs. 47 min, p ¼ 0.03). Hospitalization/ Respiratory exacerbations Significantly higher incidence of respiratory hospitalizations and pneumonias prior to introduction of IPPV, compared to after IPPV introduction Quality of life Patient satisfaction

CANADIAN JOURNAL OF RESPIRATORY, CRITICAL CARE, AND SLEEP MEDICINE 37 9 years old. 57 PCF thresholds cannot therefore be applied to younger children. A retrospective study of older children with neuromuscular disease (age 12.7 to 3.7 years) found that thresholds of inspired vital capacity (IVC) < 1.1 L and PCF <160 L/minute were useful to discriminate between individuals with and without previous severe chest infections, 58 a finding previously demonstrated in adult patients. 59 Pediatric thresholds of PCF are therefore still not well-defined. The use of LVR has been recommended by some in patients with neuromuscular disease and impaired cough, not only during times of infection or exacerbation, but also regularly once or twice daily, to ensure familiarity with the technique. 8,31 The paucity of long-term clinical studies to demonstrate efficacy of LVR, however, and the lack of controlled trials evaluating the impact of its routine use have left several groups worldwide calling for further prospective, controlled studies. 5,31,34,60 62 It remains, however, an additional tool that may assist with respiratory health maintenance, in individuals with impaired cough efficacy and/or reduced vital capacity. Airway clearance techniques for children ventilated via tracheostomy Cough functionality is further impaired in children with neuromuscular weakness who also have a tracheostomy, which bypasses the glottis. Presence of an endotracheal or tracheostomy tube also impairs mucociliary clearance and may increase risk of infection. 63 Suctioning via catheter is effective at removing secretions from the large airways in individuals with artificial airways. 64,65 This practice is largely guided by clinical experience, rather than rigorous clinical studies, which are lacking to inform this practice. However, techniques to mobilize secretions from the peripheral airways are still needed. Suctioning is not a benign intervention and deep suctioning has been associated with airway trauma, alveolar collapse and hypoxemia. 66 Shallow, minimally invasive suctioning, to the tip of the tracheostomy tube, is preferred. 64,67 The recommended suctioning technique includes use of a premeasured catheter with side holes close to the distal end (0.5 cm or less) of the catheter tube, inserted to a premeasured depth so that the most distal side holes just exit the tip of the tracheostomy tube. 64 It is recommended that the largest size catheter that fits inside the tracheostomy be used and that a rapid technique, completed in less than 5 seconds, be employed. 64 Deeper suctioning may occasionally be necessary, for example, in the presence of a mucus plug below the level of the tracheostomy tube. 67 Clean, rather than sterile, technique is recommended for suctioning in home care. 64 Sterile conditions are required in hospital where multiple caregivers are involved and the environmental bacteria are more frequent. 68 Additional adjunctive treatments to enhance airway clearance in this population include increasing patient mobility and repositioning, which may aid in moving secretions, 65,66 and the use of heated humidity, which thins secretions, rendering them easier to mobilize. 64,65,69 The use of heat/moisture exchangers (HME) is generally not as effective as heated humidity and is associated with increased dead space, minute ventilation, work of breathing, hypercapnia and respiratory rate. 70 72 HMEs are useful adjuncts to provide humidity for a mobile patient when leaving the home. It is important to note that using an HME during periods of sleep is not recommended. In addition, HMEs need to be used cautiously in children with smaller caliber tracheostomy tubes, given the increased risk of tracheostomy tube blockage. Tracheostomized patients also require adequate fluid intake to avoid dehydration, which can result in inspissated secretions. A number of clinicians have used the MI-E device in critical care patients with tracheostomies, with anecdotal benefit. 68 This has also not been rigorously studied. It is most effectively used in this context with a cuffed tracheostomy or endotracheal tube, in order to minimize air leak. 68 It is most effective when employed in conjunction with suctioning, so that secretions mobilized into the proximal airways during in-exsufflation can be removed with the suction catheter. Conclusion Manual and mechanical in-exsufflation can be used for airway clearance and have been shown in observational and cohort studies to have benefits in individuals with impaired cough. Given the lack of pediatric literature and/or randomized controlled trials, the optimal role and applications of this therapy needs further study, particularly in invasively ventilated patients. Similarly, additional airway clearance modalities, including IPPV and HFCWO, are not wellstudied, but may be beneficial in select patients. Suctioning remains the standard of care for airway clearance in tracheostomized individuals. Research questions 1. Does regular LVR use slow the decline in lung function, decrease respiratory infections and/or improve survival or quality of life in children with impaired cough? 2. What is the optimal timing for initiation and frequency of use of LVR techniques in children with impaired cough? 3. Does the use of LVR techniques during respiratory infections and/or atelectasis hasten recovery? 4. What are the optimal pressure settings for manual insufflation and MI-E in children? 5. What is the efficacy of IPPV (intrapulmonary percussive ventilation) and HFCWO in children with impaired cough? 6. Are LVR, IPPV and HFCWO effective airway clearance modalities in invasively ventilated children? Recommendations for airway clearance in children using long-term mechanical ventilation at home Patients using NIV 1. Airway clearance techniques should be taught to children and caregivers as a preventative strategy in those with evidence of impaired cough, especially if they have had

38 S. KATZ episodes of deterioration with respiratory infections. (Grade 1C) 2. In the absence of contraindications, manual and/or mechanical lung volume recruitment techniques should be introduced for children with impaired cough (defined by clinical assessment and/or MEP <60 cm H 2 O and/or PCF in children 12 years <270 L/min and/or FVC <40% predicted). (Grade 2C) 3. Mechanical lung volume recruitment techniques (i.e., mechanical in-exsufflation) should be considered in very weak children, those with loss of bulbar function and those who cannot cooperate with manual lung volume recruitment techniques or in whom the methods are not effective. (Grade 1C) 4. High Frequency Chest Wall Oscillation (HFCWO) and Intra-Pulmonary Percussive Ventilation (IPPV) could be considered for patients with impaired cough with atelectasis/consolidation, despite use of other airway clearance techniques. (Consensus) Patients ventilated via tracheostomy 1. Minimally invasive rather than deep suctioning is recommended when possible. (Grade 2B) 2. Heated humidity is recommended over heat-humidity exchangers. (Grade 1A) 3. Clean, as opposed to sterile, conditions are adequate for home secretion clearance and suctioning. (Grade 2C) 4. Mechanical in-exsufflation and manual LVR for tracheostomy airway clearance should be considered through the tracheostomy to complement deep suctioning. (Grade 2C) 5. Adequate hydration (optimized fluid intake) is essential to maintain thin, easily cleared secretions, especially in infants. (Grade 2C) 6. High Frequency Chest Wall Oscillation (HFCWO) and Intra-Pulmonary Percussive Ventilation (IPPV) could be considered for patients with impaired cough with atelectasis/consolidation, despite use of other airway clearance techniques. (Consensus) 7. Mechanical lung volume recruitment (i.e., mechanical inexsufflation) should be available in the acute-care setting in all hospitals that treat children using HMV with the purpose of preventing deterioration. (Grade 2C) References 1. Leith DE, Butler JP, Sneddon SL, Brain JD. Cough. In: Macklem PT, Mead J, editors. Handbook of Physiology. Bethesda, MD: American Physiological Society; 1986: 315 36. 2. [Anonymous]. Expiratory flow rate: standard values for normal subjects. Am Rev Resp Dis. 1963;88:644 651. 3. Gomez-Merino E, Bach JR. Duchenne muscular dystrophy: prolongation of life by noninvasive ventilation and mechanically assisted coughing. Am J Phys Med Rehabil. 2002;81(6):411 415. 4. Bach JR, Ishikawa Y, Kim H. Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest. 1997; 112(4):1024 1028. 5. Chatwin M, Ross E, Hart N, Nickol AH, Polkey MI, Simonds AK. Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness. Eur Respir J. 2003;21(3):502 508. 6. Bach JR. Mechanical insufflation/exsufflation: has it come of age? A commentary. Eur Respir J. 2003;21(3):385 386. 7. Kang SW, Bach JR. Maximum insufflation capacity. Chest 2000;118(1):61 65. 8. Kravitz RM. Airway clearance in Duchenne muscular dystrophy. Pediatrics 2009;123(Supplement 4):S231 S235. 9. Panitch HB. Airway clearance in children with neuromuscular weakness. Curr Opin Pediatr. 2006;18(3):277 281. 10. Bott J, Agent P. Physiotherapy and nursing during noninvasive positive pressure ventilation. In: Simonds AK, ed. Non-Invasive Respiratory Support: A Practical Handbook. London: Arnold; 2001:230 247. 11. Finder JD, Birnkrant D, Carl J. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med. 2004;170(4):456 465. 12. Dohna-Schwake C, Ragette R, Teschler H, Voit T, Mellies U. IPPB-assisted coughing in neuromuscular disorders. Pediatr Pulmonol. 2006;41(6):551 557. 13. Tzeng AC, Bach JR. Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest 2000;118(5):1390 1396. 14. Bach JR, Alba AS, Bodofsky E, Curran FJ, Schultheiss M. Glossopharyngeal breathing and noninvasive aids in the management of post-polio respiratory insufficiency. Birth Defects: Original Article Series 1987;23(4):99 113. 15. Bach JR, Bianchi C, Vidigal-Lopes M, et al. Lung inflation by glossopharyngeal breathing and "air stacking" in Duchenne muscular dystrophy. Am J Phys Med Rehabil. 2007;86(4):295 300. 16. Bach JR. Mechanical insufflation-exsufflation. Comparison of peak expiratory flows with manually assisted and unassisted coughing techniques. Chest. 1993;104(5):1553 1562. 17. Trebbia G, Lacombe M, Fermanian C, et al. Cough determinants in patients with neuromuscular disease. Respir Physiol Neurobiol. 2005;146(2 3):291 300. 18. Kang SW. Pulmonary rehabilitation in patients with neuromuscular disease. Yonsei Med J. 2006;47(3):307 314. 19. Marchant WA, Fox R. Postoperative use of a cough-assist device in avoiding prolonged intubation. Br J Anaesth. 2002;89(4): 644 647. 20. Homnick DN. Mechanical insufflation-exsufflation for airway mucus clearance. Respir Care. 2007;52(10):1296 1305. 21. Collier C, Dail C, Affeldt J. Mechanics of glossopharyngeal breathing. J Appl Physiol. 1956;8(6):580 584. 22. Sivasothy P, Brown L, Smith IE, Shneerson JM. Effect of manually assisted cough and mechanical insufflation on cough flow of normal subjects, patients with chronic obstructive pulmonary disease (COPD), and patients with respiratory muscle weakness. Thorax 2001;56(6):438 444. 23. Bach JR, Smith WH, Michaels J, et al. Airway secretion clearance by mechanical exsufflation for post-poliomyelitis ventilatorassisted individuals. Arch Phys Med Rehabil. 1993;74(2):170 177. 24. Bach JR, Mahajan K, Lipa B, Saporito L, Goncalves M, Komaroff E. Lung insufflation capacity in neuromuscular disease. Am J Phys Med Rehabil. 2008;87(9):720 725. 25. Bach JR, Baird JS, Plosky D, Navado J, Weaver B. Spinal muscular atrophy type 1: management and outcomes. Pediatr Pulmonol. 2002;34(1):16 22. 26. Bach JR. Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory AIDS. [see comment]. Chest 2002; 122(1):92 98. 27. Bach JR, Goncalves M. Ventilator weaning by lung expansion and decannulation. Am J Phys Med Rehabil. 2004;83(7):560 28. Vianello A, Corrado A, Arcaro G, et al. Mechanical insufflationexsufflation improves outcomes for neuromuscular disease patients with respiratory tract infections. Am J Phys Med Rehabil. 2005;84(2):83 88.

CANADIAN JOURNAL OF RESPIRATORY, CRITICAL CARE, AND SLEEP MEDICINE 39 29. Servera E, Sancho J, Zafra MJ, Catala A, Vergara P, Marın J. Alternatives to endotracheal intubation for patients with neuromuscular diseases. Am J Phys Med Rehabil. 2005;84(11):851 857. 30. Ottonello G, Mastella C, Franceschi A, et al. Spinal muscular atrophy type 1: avoidance of hospitalization by respiratory muscle support. Am J Phys Med Rehabil. 2011;90(11):895 900. 31. Miske LJ, Hickey EM, Kolb SM, Weiner DJ, Panitch HB. Use of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough. Chest 2004;125(4):1406 1412. 32. Oskoui M, Levy G, Garland CJ, et al. The changing natural history of spinal muscular atrophy type 1. Neurology 2007;69(20): 1931 1936. 33. Winck JC, Goncalves MR, Lourenco C, Viana P, Almeida J, Bach JR. Effects of mechanical insufflation-exsufflation on respiratory parameters for patients with chronic airway secretion encumbrance. Chest. 2004;126(3):774 780. 34. Fauroux B, Guillemot N, Aubertin G, et al. Physiologic benefits of mechanical insufflation-exsufflation in children with neuromuscular diseases. Chest. 2008;133(1):161 168. 35. Suri P, Burns SP, Bach JR. Pneumothorax associated with mechanical insufflation-exsufflation and related factors. Am J Phys Med Rehabil. 2008;87(11):951 955. 36. Finder JD. Airway clearance modalities in neuromuscular disease 1. Paediatr Respir Rev. 2010;11(1):31 34. 37. Toussaint M, Boitano LJ, Gathot V, Steens M, Soudon P. Limits of effective cough-augmentation techniques in patients with neuromuscular disease. Respir Care. 2009;54(3):359 366. 38. Lange DJ, Lechtzin N, Davey C, et al. High-frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial. Neurology. 2006;67(6):991 997. 39. Chaisson KM, Walsh S, Simmons Z, Vender RL. A clinical pilot study: high frequency chest wall oscillation airway clearance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2006;7(2):107 111. 40. Yen Ha TK, Bui TD, Tran AT, Badin P, Toussaint M, Nguyen AT. Atelectatic children treated with intrapulmonary percussive ventilation via a face mask: clinical trial and literature overview. Pediatr Int. 2007;49(4):502 507. 41. Birnkrant DJ, Pope JF, Lewarski J, Stegmaier J, Besunder JB. Persistent pulmonary consolidation treated with intrapulmonary percussive ventilation: a preliminary report. Pediatr Pulmonol. 1996;21(4):246 249. 42. Toussaint M, De WH, Steens M, Soudon P. Effect of intrapulmonary percussive ventilation on mucus clearance in duchenne muscular dystrophy patients: a preliminary report. Respir Care. 2003;48(10):940 947. 43. Deakins K, Chatburn RL, Deakins K, Chatburn RL. A comparison of intrapulmonary percussive ventilation and conventional chest physiotherapy for the treatment of atelectasis in the pediatric patient. Respir Care. 2002;47(10):1162 1167. 44. Crescimanno G, Marrone O. High frequency chest wall oscillation plus mechanical in-exsufflation in Duchenne muscular dystrophy with respiratory complications related to pandemic Influenza A/H1N1. Rev Port Pneumol. 2010;16(6):912 916. 45. Keating JM, Collins N, Bush A, Chatwin M. High-frequency chest-wall oscillation in a noninvasive-ventilation-dependent patient with type 1 spinal muscular atrophy. Respir Care. 2011; 56(11):1840 1843. 46. Yuan N, Kane P, Shelton K, et al. Safety, tolerability, and efficacy of high-frequency chest wall oscillation in pediatric patients with cerebral palsy and neuromuscular diseases: an exploratory randomized controlled trial. J Child Neurol. 2010;25(7):815 821. 47. Jackson C, Moore DH, Kittrell P, et al. High-frequency chest wall oscillation therapy in amyotrophic lateral sclerosis. J Clin Neuromusc Dis. 2006;8(2):60 64. 48. Plioplys A, Lewis S, Kasnicka I. Pulmonary vest therapy in pediatric long-term care. J Am Med Dir Assoc. 2002;3(5):318 321. 49. Poponick JM, Jacobs I, Supinski G, DiMarco AF. Effect of upper respiratory tract infection in patients with neuromuscular disease. Am J Respir Crit Care Med. 1997;156(2 Pt 1):659 664. 50. Bach JR, Alba AS, Saporito LR. Intermittent positive pressure ventilation via the mouth as an alternative to tracheostomy for 257 ventilator users. Chest. 1993;103(1):174 182. 51. Sancho J, Servera E, Vergara P, Marin J. Mechanical insufflationexsufflation vs. tracheal suctioning via tracheostomy tubes for patients with amyotrophic lateral sclerosis: a pilot study. Am J Phys Med Rehabil. 2003;82(10):750 753. 52. Bach JR. Medical necessity for CoughAssist TM cough stimulating device for person with neuromuscular disease (NMD) or highlevel spinal cord injury (SCI). DoctorBach. 2002. www. DoctorBach.com 53. Boitano LJ. Equipment options for cough augmentation, ventilation, and noninvasive interfaces in neuromuscular respiratory management. Pediatrics 2009;123(Supplement 4):S226 S230. May 54. Birnkrant DJ, Bushby KM, Amin RS, et al. The respiratory management of patients with duchenne muscular dystrophy: a DMD care considerations working group specialty article. Pediatr Pulmonol. 2010;45(8):739 748. 55. Bushby K, Finkel R, Birnkrant DJ, et al. DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care [Erratum appears in Lancet Neurol. 2010;9(3):237]. Lancet Neurol. 2010;9(2):177 189. 56. Birnkrant DJ. The American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Pediatrics. 2009;123(Supplement 4):S242 S244. 57. Bianchi C, Baiardi P, Bianchi C, Baiardi P. Cough peak flows: standard values for children and adolescents. Am J Phys Med Rehabil. 2008;87(6):461 467. 58. Dohna-Schwake C, Ragette R, Teschler H, Voit T, Mellies U. Predictors of severe chest infections in pediatric neuromuscular disorders. Neuromuscul Disord. 2006;16(5):325 328. 59. Bach JR, Saporito LR. Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure. A different approach to weaning. Chest. 1996;110(6):1566 1571. 60. Finder JD. A 2009 perspective on the 2004 American Thoracic Society statement, "Respiratory care of the patient with Duchenne muscular dystrophy". Pediatrics. 2009;123(Supplement 4): S239 S241. 61. Mellies U, Dohna-Schwake C, Voit T. Respiratory function assessment and intervention in neuromuscular disorders. Curr Opin Neurol. 2005;18(5):543 547. 62. Lahrmann H, Wild M, Zdrahal F, Grisold W. Expiratory muscle weakness and assisted cough in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4(1):49 51. 63. Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilatorassociated pneumonia: its relevance to developing effective strategies for prevention. Respir Care. 2005;50(6):725 739. 64. Sherman JM, Davis S, Albamonte-Petrick S, et al. Care of the child with a chronic tracheostomy. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000; 161(1):297 308. 65. Branson RD. Secretion management in the mechanically ventilated patient. Respir Care. 2007;52(10):1328 1342. 66. Day T, Farnell S, Wilson-Barnett J. Suctioning: a review of current research recommendations. Intensive Crit Care Nurs. 2002;18(2):79 89. 67. Van de Leur JP, Zwaveling JH, Loef BG, Van der Schans CP. Endotracheal suctioning versus minimally invasive airway suctioning in intubated patients: a prospective randomised controlled trial. Intensive Care Med. 2003;29(3):426 432. 68. Road J, McKim D, Avendano M, et al. Home mechanical ventilation. A Canadian Thoracic Society Clinical Practice Guideline. Can Respir J. 2011;18(4):197 215. 69. [Anonymous]. AARC clinical practice guideline. Humidification during mechanical ventilation. American Association for Respiratory Care. Respir Care 1992;37(8):887 890.

40 S. KATZ 70. Pelosi P, Solca M, Ravagnan I, Tubiolo D, Ferrario L, Gattinoni L. Effects of heat and moisture exchangers on minute ventilation, ventilatory drive, and work of breathing during pressure-support ventilation in acute respiratory failure. Crit Care Med. 1996; l24(7):1184 1188. 71. Jaber S, Chanques G, Matecki S, et al. Comparison of the effects of heat and moisture exchangers and heated humidifiers on ventilation and gas exchange during non-invasive ventilation. Intensive Care Med. 2002;28(11):1590 1594. 72. Campbell RS, Davis K, Jr., Johannigman JA, Branson RD. The effects of passive humidifier dead space on respiratory variables in paralyzed and spontaneously breathing patients. Respir Care 2000;45(3):306 312. 73. Chatwin M, Simonds AK. The addition of mechanical insufflation/ exsufflation shortens airway-clearance sessions in neuromuscular patients with chest infection. Respir Care. 2009;54(11):1473 1479. 74. McKim DA, Katz SL, Barrowman N, Ni A, LeBlanc C. Lung volume recruitment slows pulmonary function decline in Duchenne muscular dystrophy. Arch Phys Med Rehabil. 2012;93(7): 1117 1122. 75. Bach JR, Wang TG. Noninvasive long-term ventilatory support for individuals with spinal muscular atrophy and functional bulbar musculature. Arch Phys Med Rehabil. 1995;76(3):213 217. 76. De Troyer A, Deisser P. The effects of intermittent positive pressure breathing on patients with respiratory muscle weakness. Am Rev Respir Dis. 1981;124(2):132 137.